Preview

Epilepsy and paroxysmal conditions

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 6, No 1 (2014) NEUROIMMUNOPATHOGENIC MECHANISMS OF EPILEPSY Abstract  similar documents
Yо. N. Madjidova, G. S. Rakhimbaeva, R. B. Azizova
"... to such neurospecific proteins as: NF-200, S100 and to two-spiral DNA. This indicated about degenerative disorders ..."
 
Vol 5, No 4 (2013) DEVELOPMENT OF THE BLOOD-BRAIN BARRIER IN THE ONTOGENESIS IN THE LIGHT OF IMMUNOHISTOCHEMICAL ANALYSIS OF NEUROSPECIFIC PROTEINS Abstract  similar documents
D. V. Blinov
"... immunochemical verification of eurospecific proteins (NSP) in biological fluids and neuroprotective therapy. ..."
 
Vol 6, No 1 (2014) СURRENT CONCEPTS OF THE ROLE OF ALTERED BLOOD-BRAIN BARRIER RESISTANCE IN THE PATHOGENESIS OF CNS DISORDERS. PART II: FUNCTIONS AND MECHANISMS OF THE BLOOD-BRAIN BARRIER DAMAGE Abstract  similar documents
D. V. Blinov
"... , carrier-mediated diffusion, carrier-mediated  transport  (liquid endocytosis,  receptor-mediated ..."
 
Vol 6, No 2 (2014) PECULIARITIES OF AMINO ACID METABOLISM IN SERUM AND CEREBROSPINAL FLUID OF PATIENTS WITH CHRONIC VIRAL ENCEPHALITIS WITH CONVULSIVE SYNDROME Abstract  similar documents
N. F. Philippovich, N. V. Staheyko
"... of the concentration of essential amino acids in the analyzed pathology of cerebrospinal fluid protein level ..."
 
Vol 11, No 1 (2019) Pathogenesis of drug resistant epilepsy Abstract  similar documents
S. M. Malyshev, T. M. Alekseeva, W. A. Khachatryan, M. M. Galagudza
"... or receptor proteins. Secondly, it might be a consequence of inherent features of epilepsy per se ..."
 
Vol 8, No 1 (2016) COMPARATIVE ANTICONVULSANT AND ANTIHYPOXIC EFFECTS OF ASTROKS AND MEXIDOL IN INJECTABLE FORM AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE SUBSTANCE Abstract  similar documents
T. A. Voronina, S. A. Litvinova, L. N. Nerobkova, G. G. Avakyan, I. O. Gaidukov, G. N. Avakyan
"... -ethyl-6-methyl-3-hydroxypyridine succinate medications — Astroks in injectable form (vial of 100 mg in 2 ..."
 
Vol 10, No 1 (2018) CELL THERAPY OF EPILEPSIA. CLINICAL AND IMMUNOLOGICAL ASPECTS Abstract  similar documents
T. V. Dokukina, M. P. Potapnev, S. M. Kosmacheva, F. P. Hlebokazov, E. L. Slobina, T. S. Golubeva, N. N. Misjuk, M. V. Mahrov, I. V. Shamruk, P. P. Korolevich, A. I. Martynenko, I. V. Bychenko, T. O. Bud’ko
"... and that for the endolumbar injection – from 5.1 to 10.0 million with viability not less than 95%. The distribution of AMSCBM ..."
 
Vol 6, No 1 (2014) MODERN TREATMENT OPTIONS FOR DRUG-RESISTANT EPILEPSY IN CHILDREN Abstract  similar documents
S. O. Aivazyan, E. G. Lukyanova, Yu. S. Shiryaev
"... : the complete elimination of seizures (100%) was observed in 28 (61%) patients, reducing the number of seizures ..."
 
Vol 3, No 3 (2011) HEADACHE ASSOCIATED WITH EXCESSIVE USAGE OF ANALGESICS: CLINICAL-PSYCHOLOGICAL AND NEUROPHYSIOLOGICAL ANALYSIS, AND SPECIFICS OF THE PERIOD OF THE PERIOD OF DRUG WITHDRAWAL Abstract  similar documents
A. V. Sergeev, M. I. Meshcherina, G. R. Tabeeva
"... amplitude response N75/P100, with an emphasis in the period of drug withdrawal and lack of habituation N75/P ..."
 
Vol 8, No 4 (2016) VII INTERNATIONAL FORUM EPILEPTOLOGISTS OF THE CIS/EURASEC «EPILEPTOLOGY AND PAROXYSMAL STATES» (October 7-8, 2016, Sochi) Abstract  similar documents
Article Editorial
"... Вработе Форума приняли участие более 200 делегатов и гостей – эпилептологов, неврологов, психиатров ..."
 
Vol 8, No 2 (2016) THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING Abstract  similar documents
T. V. Dokukina, A. I. Startsev, M. V. Makhrov, I. V. Haidukevich, T. S. Golubeva, A. A. Gilep, E. A. Sheremet, I. V. Shamruk, A. S. Pinchuk, S. A. Marchuk, F. P. Khlebokazov, N. N. Misyuk
"... of enzyme systems and proteins-transporters of drugs. Materials and Methods. During 4 years in the study ..."
 
Vol 8, No 4 (2016) NONCONVULSIVE STATUS EPILEPTICUS IN PATIENTS WITH LIMBIC ENCEPHALITIS Abstract  similar documents
M. A. Sherman, I. V. Ardashev, I. V. Ponomareva, H. Sherman
"... -receptor encephalitis in a young women: a diagnostic challenge. RJN. 2014; XIII (4): 200-211. 48. Sethi ..."
 
Vol 8, No 2 (2016) PROTECTION OF BRAIN MITOCHONDRIA AGAINST MICRO STROKE-INDUCED INJURY: A STUDY OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN EXPERIMENTAL MODEL USING TWO PHOTON LASER FLUORESCENT MICROSCOPY Abstract  similar documents
R. A. Afzalov, Yu. O. Kolikova, E. G. Pryazhnikov, D. V. Toptunov, L. S. Khirug
"... was induced in Thy1-CFP-MitoS mice expressing cyano fluorescent protein (CFP) in brain mitochondria by impulse ..."
 
Vol 7, No 4 (2015) NEW BIOMOLECULAR TARGETS FOR ANTIEPILEPTIC DRUGS Abstract  similar documents
T. A. Voronina, G. G. Avakyan, L. N. Nerobkova, S. A. Litvinova, G. N. Avakyan
"... glutamate receptors; AEDs, activating the ionic conductivity of K+ channels; AEDs, enhancing the braking ..."
 
Vol 10, No 1 (2018) EFFECTS OF LEVETINOL ON EPILEPTIFORM ACTIVITY OF THE BRAIN IN RATS WITH COBALT-INDUCED EPILEPSY Abstract  similar documents
S. A. Litvinova, T. A. Voronina, L. N. Nerobkova, I. S. Kutepova, G. G. Avakyan, G. N. Avakyan
"... that at the early stage of ES development, Levetinol at doses of 50 and 200 mg/kg had no statistically significant ..."
 
Vol 11, No 1 (2019) Mutation of the ALDH7A1 gene in a patient with pyridoxal phosphate-dependent neonatal epileptic encephalopathy: a clinical case Abstract  similar documents
T. V. Kozhanova, S. S. Zhilina, T. I. Mescheryakova, E. G. Lukyanova, K. V. Osipova, S. O. Ayvazyan, A. G. Prityko
"... (previously not described). This mutation led to the appearance of a stop codon in position 82 of the protein ..."
 
Vol 5, No 3 (2013) PROBLEMS OF PARANEOPLASTIC LIMBIC ENCEPHALITIS DIAGNOSIS Abstract  similar documents
N. A. Shnayder, D. V. Dmitrenko, Yu. A. Dykhno, V. V. Ezhikova
"... -иммунологические ассоциа- ции, например, связь анти-Hu антител и мелкокле- точного рака легкого (МРЛ), анти-Ma2 ..."
 
Vol 6, No 2 (2014) STUDY OF THE INCIDENCE AND PREVALENCE OF EPILEPSY IN MINSK Abstract  similar documents
T. V. Dokukina, T. S. Golubeva, I. V. Matveichuk, M. V. Mahrov, V. M. Loseva, E. V. Krupenkina, S. A. Marchuk
"... ranged from 165.2 per 100,000 population in 2008 to 275.5 per 100,000 population in 2012; incidence ..."
 
Vol 2, No 4 (2010) STATISTICAL-EPIDEMIOLOGICAL STUDY OF NEUROLOGICAL DISEASE MORBIDITY IN CHILDREN'S HOSPITAL Abstract  similar documents
D. V. Blinov, S. I. Sandukovskaya
"... (gliofibrillary acid protein — GFAP), белка S-100 (S-100 protein), фак- тора роста сосудистого эндотелия ..."
 
Vol 6, No 1 (2014) CHANGES OF PERIFERAL BLOOD PARAMETERS AND IMMUNOLOGICAL STATUS OF PATIENTS WITH CHRONICAL HERPETIC INFECTION WITHOUT ANT WITH SYMPTOMATIC FOCAL EPILEPSY Abstract  similar documents
S. V. Krijzhanovskaya, N. L. Kamzalakova, N. A. Shnayder, Yu. S. Panina
"... in patients 2 and 3 groups of 100% of the cases were shown specific G class antibodies to HSV, a high titer ..."
 
Vol 4, No 4 (2012) EXPERIENCE OF TREATMENT WITH GENERIC LAMOTRIDJIN IN DIFFERENT FORMS OF EPILEPSY (The results of focus observation in out-patient clinics network of Moscow city public healthcare services) Abstract  similar documents
O. L. Badalyan, M. A. Bogomazova, I. I. Zhuravleva, A. M. Ismailov, . ., E. G. Komelkova, L. N. Lesinker, Yu. I. Logvinov, O. V. Otcheskaya, S. V. Petrov, Yu. V. Solomatin, A. M. Teplysheva, T. N. Udovuchenko, A. E. Khromykh, A. S. Chukanova, A. V. Lebedeva, S. G. Burd, A. N. Boiko
"... 200 75 Да 2000 8 250 50 Да 1000 6 100 100 Да 2000 8 150 100 Да 1000 4 50 50 Отменен из-за силь ..."
 
Vol 6, No 1 (2014) EFFICACY AND TOLERABILITY OF PERAMPANEL AS ADDITIONAL DRUG OF TEENAGERS WITH DRUG-RESISTANT PARTIAL EPILEPSY: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY CONDUCTED IN THE RUSSIAN FEDERATION Abstract  similar documents
E. D. Belousova
"... became more evident in open phase of the trial – at 78th week of the trial all patients – 23/23 (100 ..."
 
Vol 8, No 3 (2016) POSSIBILITIES OF TIC HYPERKINESIA THERAPY USING ANTIСONVULSANTS Abstract  similar documents
V. P. Zykov, E. A. Kashirina, Yu. V. Naugolnykh
"... ,4±110,5** 1299,4±89,8 340,3±10,5* 0 200 400 600 800 1000 1200 1400 1600 1800 2000 m. Orbicularis ..."
 
Vol 2, No 3 (2010) NEURO-IMMUNE MECHANISM OF EPILEPSY AS A KEY TO PATHOGENETIC TREATMENT OF THE DISEASE Abstract  similar documents
L. V. Lipatova
"... , свидетельствующие о взаимосвязи эпилепсии с иммунологической дезорганизацией, что позволило отнести этот вид ..."
 
Vol 6, No 2 (2014) EPIDEMIOLOGY OF FEBRILE SEIZURES IN CHILHOOD POPULATION AT KRASNOYARSK CITY Abstract  similar documents
G. P. Martynova, N. A. Shnayder, M. A. Stroganova
"... . The prevalence of FS among children aged 0-14 years old ranged from 75 to 112 per 100 000 childhood population ..."
 
Vol 6, No 3 (2014) IMMUNE DISTURBANCES IN PATIENTS WITH EPILEPSY AND OPPORTUNITY OF IMMUNOMODULATION BY RECOMBINANT HUMAN IL-2 Abstract  similar documents
L. V. Lipatova, N. B. Serebryanya, N. A. Sivakova, A. V. Vasilenko, T. V. Kapustina
"... . Затем плату промывали, до- бавляя в каждую лунку по 150 мкл жидкости. С помо- щью LuminexW 200 ..."
 
Vol 4, No 4 (2012) EXPERIENCE OF TREATMENT OF DIFFERENT FORMS OF EPILEPSY WITH GENERIC TOPIRAMATE (The results of focus observation in out-patientclinics network of Moscow city public healthcare services) Abstract  similar documents
O. L. Badalyan, M. A. Bogomazova, I. I. Zhuravleva, A. M. Ismailov, E. G. Komelkova, L. N. Lesinker, Yu. I. Logvinov, O. V. Otcheskaya, S. V. Petrov, Yu. V. Solomatin, A. М. Teplysheva, T. N. Udovuchenko, E. A. Khromykh, A. S. Chukanova, A. V. Lebedeva, S. G. Burd, A. N. Boiko,
"... отменен - - 7 200, моно 75 200 Нет 200 200 75 8 100, поли 25 100 Нет 150 150 Ремиссия 9 150, моно 75 200 ..."
 
Vol 5, No 2 (2013) EXPERIENCE WITH THE DRUG MEMANTINE IN PATIENTS WITH FOCAL EPILEPSY AND COGNITIVE IMPAIRMENT Abstract  similar documents
Yu. V. Solomatin, V. V. Kurbatova, I. E. Serdyuk, Yu. I. Logvinov, M. M. Shamokhova, S. G. Burd, A. V. Lebedeva
"... observations efficiency NMDA-receptor antagonist: This drug memantine (Noodzheron). The study involved 50 ..."
 
Vol 4, No 1 (2012) CLINICAL-EPIDEMIOLOGICAL EPILEPSY CHARACTERISTICS IN TRANSBAIKALIA Abstract  similar documents
Yu. A. Kritskaya, N. A. Shnayder, Yu. A. Shirshov
"... population is 3,66 and 3,46 cases per 1,000 population, and incidence – 21,59 and 20,71 cases per 100 ..."
 
Vol 9, No 2 (2017) 4-BENZOYLPYRIDINE OXIME DERIVATIVE (GIZH-298) VERSUS VALPROIC ACID: THE ANTICONVULSANT POTENTIAL EFFECT IN A MODEL OF EPILEPSY IN RATS WITH COBALT-INDUCED LESIONS Abstract  similar documents
I. O. Gaydukov, S. A. Litvinova, T. A. Voronina, L. N. Nerobkova, L. A. Zhmurenko, G. V. Mokrov, G. G. Avakyan, I. S. Kutepova
"... ), in the hippocampus and hypothalamus (28-fold decrease); eliminates (in 100% of the animals) the generalized tonic ..."
 
Vol 7, No 2 (2015) CLINICAL CASE OF PREGNANT PATIENT WITH TEMPORAL EPILEPSY AND MYOCLONIC EPILEPTIC SEIZURES Abstract  similar documents
V. O. Generalov, T. R. Sadykov, N. I. Klimenchenko, A. M. Yugay, Yu. V. Kazakova, E. V. Tsalagova, O. V. Shetikova
"... приема клоназепама 0,25 мг/сут. и бензо- нала 100 мг/сут. отмечено урежение вторично- генерализованных ..."
 
Vol 10, No 2 (2018) Chromatography-tandem MASS spectrometry (HPLC-MS/MS) for the detection of valproic acid and its metabolites in blood plasma Abstract  similar documents
A. S. Malygin, N. S. Popov, M. A. Demidova, M. N. Kudrayshova
"... the range from 1 mcg/ml to 200 mcg/ml of valproic acid. For the mass  spectroscopy detection of valproic ..."
 
Vol 1, No 1 (2009) VISUAL EVOKED POTENTIALS OF SICK INFANTS WITH EPILEPSY Abstract  similar documents
V. P. Zykov, I. M. Mosin, D. L. Safronov, E. B. Izumova, I. L. Stepanishev, O. A. Voronenko
"... , the third – 10 healthy infants. The maximum delay of latency (37,4 ± 30 мс) of component Р100 of the visual ..."
 
Vol 10, No 3 (2018) High-frequency bioelectrical activity of the brain in the diagnosis of epilepsy Abstract  similar documents
N. D. Sorokina, S. S. Pertsov, G. V. Selitsky
"... ) and high frequency (100-1000 Hz) as well as super-high (>1000 Hz) frequency oscillations, as recorded ..."
 
Vol 5, No 3 (2013) CURRENT CONCEPTS OF THE ROLE OF ALTERED BLOOD-BRAIN BARRIER RESISTANCE IN THE PATHOGENESIS OF CNS DISORDERS. PART I: STRUCTURE AND FORMATION OF THE BLOOD-BRAIN BARRIER Abstract  similar documents
D. V. Blinov
"... плотных контактов различают zonula adhaerens, где ширина межклеточной щели около 200А, и zonula ..."
 
Vol 8, No 2 (2016) CLINICAL AND GENETIC HETEROGENITY OF JUVENILE MYOCLONIC EPILEPSY Abstract  similar documents
N. A. Shnayder, O. S. Shilkina, K. V. Petrov, I. A. Chernykh, A. V. Diuzhakova
"... ген и уточнен тип наследования. Известно, что ген EFHC1 (EF Hand Containing 1 protein, англ.) на ..."
 
Vol 4, No 2 (2012) NEW METHODS OF OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY: USE OF BAYESIAN PHARMACOKINETIC MODELING Abstract  similar documents
Z. А. Suslina, А. K. Sariev, D. А. Аbaimov, T. YU. Noskova, R. D. Sejfulla, V. V. Shvedkov, D. I. Prokhorov, M. V. Shiryaeva, L. А. Mota
"... -400 Урежение >75% 600-0-600 20 Жен, 52 СФЭ 100-0-100 Ремиссия 100-0-100 21 Жен, 45 СФЭ 200-0-200 ..."
 
Vol 6, No 1 (2014) CLINICAL LATERALIZING SIGNS IN SYMPTOMATIC TEMPORAL LOBE EPILEPSY Abstract  similar documents
M. A. Nikitina, K. Yu. Mukhin, L. Yu. Glukhova, V. A. Chadaev, E. I. Barletova
"... signs and it is lateralized in contralateral hemisphere in 100% of cases. It is shown that the “early ..."
 
Vol 7, No 2 (2015) CLINICAL LATERALIZING SIGNS IN SYMPTOMATIC TEMPORAL LOBE EPILEPSY Abstract  similar documents
M. A. Nikitina, K. Yu. Mukhin, L. Yu. Glukhova, V. A. Chadaev, E. I. Barletova
"... signs and it is lateralized in contralateral hemisphere in 100% of cases. It is shown that the "early ..."
 
Vol 10, No 4 (2018) Epilepsy combined with Wolf-Hirschhorn syndrome: a literature review and description of clinical cases Abstract  similar documents
M. B. Mironov, N. V. Chebanenko, S. O. Ayvazyan, S. A. Vladimirova, K. V. Osipova, S. G. Burd, Yu. V. Rubleva, T. M. Krasilshchikova, V. G. Bychenko
"... of epilepsy in patients with WHS (50-100% of cases), an early debut of seizures (mainly in the first year ..."
 
Vol 4, No 4 (2012) CLINICAL AND DIAGNOSTIC FEATURES OF EPILEPSY WITH ACCOMPANYING (INACTIVE) ORGANIC ENCEPHALOPATHY Abstract  similar documents
S. A. Gromov, A. A. Kolyada, Y. N. Khrolenkov
"... кросскорелляционный анализ ЭЭГ, МРТ головного мозга, иммунологический маркер- ный анализ. Методы фрактального (ФА) и ..."
 
Vol 7, No 4 (2015) EPILEPSY IN CHILDREN WITH STROKE Abstract  similar documents
I. O. Shchederkina, N. N. Zavadenko, I. E. Koltunov
"... .3 to 13/100 000). The children identified more than 100 risk factors for stroke, but more than a third ..."
 
Vol 6 (2014): Special issue ПЕРАМПАНЕЛ: ФАРМАКОКИНЕТИКА И ЛЕКАРСТВЕННЫЕ ВЗАИМОДЕЙСТВИЯ Abstract  similar documents
"... ), биодоступность составляет ~100%. Пресистем- ный метаболизм препарата является незначительным и объем ..."
 
Vol 3, No 3 (2011) VARIANTS OF THE GENERALIZATION OF EPILEPTIC SEIZURES IN MESIAL TEMPORAL EPILEPSY IN ADULTS Abstract  similar documents
V. О. Generalov, Т. R. Sadykov, Yu. ВV. Kazakova, Е. V. Amcheslavskaya
"... with epilepsy against chronic abusing alcohol (100 patients), patients with epilepsy against a chronic ischemia ..."
 
Vol 10, No 1 (2018) EPILEPTIC ENCEPHALOPATHIES WITH ELECTRICAL STATUS EPILEPTICUS OF SLOW-WAVE SLEEP (ESES): DIAGNOSIS AND PHARMACOTHERAPY Abstract  similar documents
A. A. Kholin
"... Electrical status epilepticus of slow sleep (ESES) is a sleep EEG pattern with a continuous (85-100 ..."
 
Vol 6, No 2 (2014) TERATOGENESIS OF ANTIEPILEPTIC DRUGS: REVIEW AND CLINICAL CASES Abstract  similar documents
D. V. Dmitrenko, N. A. Shnayder
"... получавших ПЭП, и 200 здо- ровых добровольцев, показало, что карбамазепин, габапентин, окскарбазепин ..."
 
Vol 2, No 1 (2010) TOPIRAMATE APPLICATION IN COMPLEX TREATMENT OF EPILEPSY Abstract  similar documents
O. L. Badalyan, A. A. Savenkov, K. H. Taisheva, O. Yu. Tertyshnik
"... 100-летию Российской Противоэпилептической Лиги Дан ная инт ерн ет-в ерс ия с тать и бы ла с ..."
 
Vol 10, No 2 (2018) Antiepileptic pharmacotherapy is the leading factor in the induced pathomorphosis of epilepsy Abstract  similar documents
M. G. Amirkhanian
"...   рационально подобрана лишь в 41 (45%) случае – у 19 (51%) М  и 22 (41%) Ж (р>0,05). Из 82 (100%) пациентов ..."
 
Vol 2, No 3 (2010) THE EFFICACY OF ANTI-EPILEPTIC TREATMENT IN ADULTS BEFORE AND AFTER ITS CORRECTION BY EPILEPTOLOGIST Abstract  similar documents
P. N. Vlasov, N. V. Orekhova
"... remission was attained in 51.2% of patients (n = 159), and seizures became rarer (>50% - <100%) in 42 ..."
 
Vol 8, No 3 (2016) THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS Abstract  similar documents
A. V. Yakunina, I. E. Poverennova
"...   (therapeutic range is 50-100 mcg/ml).  The  research determined the presence  of significant individual ..."
 
1 - 50 of 164 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)